NCT05679193View on ClinicalTrials.gov

Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

November 28, 2023

Study Completion Date

January 27, 2024

Conditions
Prostate Cancer
Interventions
DRUG

Propranolol

"Propranolol capsules 20mg taken orally.~Day: 1-3:~20mg twice daily~Day: 4-19 (25 , In cases of delayed RALP an extension of up to 6 days is allowed.in cases of delayed surgery).~2x 20mg twice daily~Day 20-22 20mg twice daily"

Trial Locations (1)

4953

Oslo University Hospital The Norwegian Radium Hospital, Oslo

All Listed Sponsors
collaborator

Ivar, Ragna og Morten Holes legat til fremme av kreftforskningen i Norge

UNKNOWN

collaborator

Fondsstiftelsen ved Oslo Universitetssykehus

UNKNOWN

lead

Oslo University Hospital

OTHER